Bloomberg Businessweek

Beyond Opioids

Researchers are unlocking the genetic underpinnings of pain to develop innovative treatments

The pain in Susan Hahla’s feet started as pins and needles, then progressed to flickering fires. Each month, Hahla found herself in a different doctor’s office, waiting for another disease to be crossed off the list: no restless leg syndrome, no rheumatism, and no, thank goodness, multiple sclerosis.

Finally, doctors at Oslo University Hospital in Norway diagnosed her with small-fiber neuropathy, a disorder caused when nerves misfire. “It gave me a good feeling that I wasn’t dreaming up something,” says Hahla, 71. But finding a treatment proved elusive. Some drugs had no effect on the pain; one, usually prescribed for epilepsy, left her forgetful and unable to walk a straight line.

After suffering for more than a

You're reading a preview, sign up to read more.

More from Bloomberg Businessweek

Bloomberg Businessweek1 min read
Case Closed
Since it was first introduced in 1992, the Kelly Dépêches briefcase from Hermès ($10,200) has been almost as sought-after as its celebrated namesake handbag. This iteration, new for fall, has a slimmer profile, a shorter flap for easier opening and c
Bloomberg Businessweek8 min read
Now, About That Yield Curve
The chance of a recession in 2020 has Democratic campaign strategists feverish with anticipation—while trying not to show it—and President Trump even more amped up than usual. While Trump says he’s confident of the strength of the U.S. economy, his a
Bloomberg Businessweek1 min read
Floyd
1 It all started with a table leg. Floyd co-founders Kyle Hoff and Alex O’Dell marketed their first product—a leg that can be clamped onto any surface to create a table—in 2014 via a Kickstarter campaign. The hardware drew 1,395 backers who pledged